EQPT.O

EQPT.O has a liquidity position that is characterized by a current ratio of 1.97, indicating a moderate ability to meet short-term obligations. The company's liquidity_fpt is constrained by a negative net cash position after subtracting total debt, which is a key liquidity flag. The price-to-book ratio of 5.88 suggests that the company is trading at a premium relative to its book value. In terms of profitability, EQPT.O's return on equity of 4.5% is below the typical industry benchmark, indicating that the company is not generating strong returns for its shareholders. The return on assets of 0.67% further underscores the company's weak asset utilization efficiency. The operating margin, calculated as operating income divided by revenue, is 6.6%, which is a modest figure and may suggest that the company is facing competitive pressures or cost management challenges. The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no significant geographic diversification reported. This concentration could expose the company to higher risk if the segment or region experiences a downturn. Looking at the growth trajectory, EQPT.O's revenue has shown a positive trend, but the exact numeric deltas for the current and next fiscal years are not provided in the available data. The company's capital expenditure of -248 million USD indicates a reduction in investment in physical assets, which could be a strategic decision to focus on operational efficiency or a sign of financial constraints. The risk assessment for EQPT.O highlights a medium liquidity risk due to the negative net cash position after subtracting total debt. The dilution risk is assessed as low, suggesting that the company is not expected to issue a significant number of new shares in the near term. The dilution potential is further supported by the fact that the number of shares outstanding for both basic and diluted scenarios is the same. Recent events, as reflected in the financial data, include a high price target of 55.00 USD and a low price target of 22.00 USD, with a mean recommendation of 2.10, indicating a generally positive outlook from analysts. The company's market price of 20.7 USD is significantly below the mean and median price targets, suggesting potential for upward movement.